The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Adamyan L.V.

Russian Medical University;
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

Kotova E.G.

Ministry of Healthcare

Gadzhieva S.M.

Ministry of Health of the Russian Federation

Vechorko V.I.

Filatov City Clinical Hospital No. 15

Chulanov V.P.

National Medical Research Center for Phthisiopulmonology and Infectious Diseases

Konysheva O.V.

Russian Medical University;
Filatov City Clinical Hospital No. 15

Kuzmin V.N.

Russian Medical University

Kharchenko E.I.

Russian Medical University

Grigoryan I.E.

Russian Medical University

Osipova A.A.

Russian Medical University

Reproductive health of women with hepatitis C (literature review and own data)

Authors:

Adamyan L.V., Kotova E.G., Gadzhieva S.M., Vechorko V.I., Chulanov V.P., Konysheva O.V., Kuzmin V.N., Kharchenko E.I., Grigoryan I.E., Osipova A.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2025;31(1): 12‑20

DOI: 10.17116/repro20253101112

Views: 389

Downloaded: 26

Download PDF (RU)
Contact the author
Table of contents

REPRODUCTIVE HEALTH OF WOMEN WITH HEPATITIS C (LITERATURE REVIEW AND OWN DATA)
REPRODUCTIVE HEALTH OF WOMEN WITH HEPATITIS C (LITERATURE REVIEW AND OWN DATA)

To cite this article:

Adamyan LV, Kotova EG, Gadzhieva SM, et al. . Reproductive health of women with hepatitis C (literature review and own data). Russian Journal of Human Reproduction. 2025;31(1):12‑20. (In Russ.)
https://doi.org/10.17116/repro20253101112

 
 
Подписка 2025-2 (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Hemo­rrhagic stroke during pregnancy as a result of rupture of cave­rnous malformation. Clinical case. Russian Journal of Human Reproduction. 2024;(2):90-95
A comparative asse­ssment of microbiocenosis of saliva and oropharynx in patients with migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):55-62
Pecu­liarities of local mRNA gene expression of pro- and anti-inflammatory cyto­kines in term pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):6-13
The problem of diabetes mellitus in obstetrics. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):25-29
Rela­tionship between pregnancy and the risk of mali­gnant neoplasms of the female reproductive system. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):48-54
Asse­ssment of the effe­ctiveness of compression therapy in pregnant women with geni­tal vari­cose veins. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):60-65
Expe­rience of combined treatment of patients with infe­rtility operated for exte­rnal geni­tal endo­metriosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):77-81
Clinical obse­rvation of successful pregnancy and deli­very of patients with giant placental chorioangioma. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):103-107
Sleep diso­rders during pregnancy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):99-104
Sensitivity of various cell cultures to human respiratory syncytial virus from clinical examination of patient. Mole­cular Gene­tics, Microbiology and Viro­logy. 2024;(2):39-44

The hepatitis C virus (HCV), being one of the leading causes of liver disease, significantly affects female reproductive function. This article examines the mechanisms by which HCV impacts fertility, reduces ovarian reserve, and alters the regulation of sex hormones associated with liver function. The article also discusses the specific characteristics of pregnancy and childbirth in women with chronic hepatitis C, including the increased likelihood of developing cholestasis, gestational diabetes, premature labor, mother-to-child transmission of the virus, and adverse perinatal outcomes. In analyzing current approaches to managing HCV patients, it is important to highlight the effectiveness of a multidisciplinary approach, the implementation of screening programs, the optimization of patient management pathways, and the coordination of efforts between infectious disease specialists, obstetricians-gynecologists, and neonatologists, as well as the provision of high-quality medical care aimed at minimizing the risks posed by hepatitis C virus to female reproductive function.

Keywords:

hepatitis C virus
reproduction
pregnancy
infection

Authors:

Adamyan L.V.

Russian Medical University;
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

Kotova E.G.

Ministry of Healthcare

Gadzhieva S.M.

Ministry of Health of the Russian Federation

Vechorko V.I.

Filatov City Clinical Hospital No. 15

Chulanov V.P.

National Medical Research Center for Phthisiopulmonology and Infectious Diseases

Konysheva O.V.

Russian Medical University;
Filatov City Clinical Hospital No. 15

Kuzmin V.N.

Russian Medical University

Kharchenko E.I.

Russian Medical University

Grigoryan I.E.

Russian Medical University

Osipova A.A.

Russian Medical University

Received:

17.10.2024

Accepted:

01.11.2024

List of references:

  1. World Health Organization. Global hepatitis report 2024: action for access in low-and middle-income countries. World Health Organization; 2024. Accessed December 18, 2024. https://www.who.int/publications/i/item/9789240091672
  2. Pimenov NN, Komarova SV, Karandashova IV, Tsapkova NN, Volchkova EV, Chulanov VP. Hepatitis C and its outcomes in Russia: analysis of incidence, prevalence and mortality rates before the start of the programme of infection elimination. Infektsionnye bolezni. 2018;16(3):37-45. (In Russ.). https://doi.org/10.20953/1729-9225-2018-3-37-45
  3. Sarkar M, Lai JC, Sawinski D, Zeigler TE, Cedars M, Forde KA. Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection. Journal of Viral Hepatitis. 2019;26(2):258-262.  https://doi.org/10.1111/jvh.13027
  4. Tang S, Yue M, Wang J, Su J, Yu R, Zhou D, Xu K, Cai L, Zhang Y, Wang J. Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population. European Journal of Clinical Microbiology and Infectious Diseases. 2014;33(6):999-1010. https://doi.org/10.1007/s10096-013-2038-y
  5. Villa E, Vukotic R, Cammà C, Petta S, Di Leo A, Gitto S, Turola E, Karampatou A, Losi L, Bernabucci V, Cenci A, Tagliavini S, Baraldi E, De Maria N, Gelmini R, Bertolini E, Rendina M, Francavilla A. Reproductive status is associated with the severity of fibrosis in women with hepatitis C. PLoS One. 2012;7(9):e44624. https://doi.org/10.1371/journal.pone.0044624
  6. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology. 2000;31(3):751-755.  https://doi.org/10.1002/hep.510310328
  7. Deuffic-Burban S, Poynard T, Valleron AJ. Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. Journal of Viral Hepatitis. 2002;9(2):114-122.  https://doi.org/10.1046/j.1365-2893.2002.00340.x
  8. Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamineinduced fibrosis of the liver in rats. Hepatology. 1999;29(3):719-727.  https://doi.org/10.1002/hep.510290307
  9. Itagaki T, Shimizu I, Cheng X, Yuan Y, Oshio A, Tamaki K, Fukuno H, Honda H, Okamura Y, Ito S. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut. 2005;54(12):1782-1789. https://doi.org/10.1136/gut.2005.053278
  10. Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology. 2004;40(6):1426-1433. https://doi.org/10.1002/hep.20463
  11. Codes L, Asselah T, Cazals-Hatem D, Tubach F, Vidaud D, Paraná R, Bedossa P, Valla D, Marcellin P. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut. 2007;56(3):390-395.  https://doi.org/10.1136/gut.2006.101931
  12. Hanson BM, Dorais JA. Reproductive considerations in the setting of chronic viral illness. American Journal of Obstetrics and Gynecology. 2017;217(1):4-10.  https://doi.org/10.1016/j.ajog.2017.02.012
  13. Karampatou A, Han X, Kondili LA, Taliani G, Ciancio A, Morisco F, Critelli RM, Baraldi E, Bernabucci V, Troshina G, Guarino M, Tagliavini S, D’Ambrosio F, Bristot L, Turco L, Rosato S, Vella S, Trenti T, Neri I, La Marca A, Manthena S, Goldstein AS, Bruno S, Bao Y, Gonzalez YS, Villa E; PITER framework investigators; PITER Investigators. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. Journal of Hepatology. 2017:S0168-8278(17)32259-6.  https://doi.org/10.1016/j.jhep.2017.08.019
  14. Yuan Y, Shimizu I, Shen M, Aoyagi E, Takenaka H, Itagaki T, Urata M, Sannomiya K, Kohno N, Tamaki K, Shono M, Takayama T. Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C. World Journal of Gastroenterology: WJG. 2008;14(14): 2200-2207. https://doi.org/10.3748/wjg.14.2200
  15. Chaykivska EF. Hormonal profile of pubertal age girls with chronic viral hepatitis. Journal of Education, Health and Sport. 2020;10(4): 342-350. 
  16. Neong SF, Billington EO, Congly SE. Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: review of pathogenesis and management. Hepatology. 2019;69(6):2683-2695. https://doi.org/10.1002/hep.30359
  17. Mazerbourg S, Monget P. Insulin-like growth factor binding proteins and IGFBP proteases: a dynamic system regulating the ovarian folliculogenesis. Frontiers in Endocrinology. 2018;9:134.  https://doi.org/10.3389/fendo.2018.00134
  18. Silva JR, Figueiredo JR, van den Hurk R. Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Theriogenology. 2009;71(8):1193-208.  https://doi.org/10.1016/j.theriogenology.2008.12.015
  19. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002;122(2):366-375.  https://doi.org/10.1053/gast.2002.30983
  20. Shaw-Jackson C, Capraro M, Ameye L, Vandromme J, Manigart Y, Rozenberg S, Autin C. In vitro fertilization for women infected by hepatitis C virus: a matched case-control study and a systematic literature review. Journal of Assisted Reproduction and Genetics. 2017;34(5):587-597.  https://doi.org/10.1007/s10815-017-0892-8
  21. Lisovskaya TV, Mal’gina GB, Perepletina TA, Medvedeva VV, Kireev DE, Shipulin GA, Pungina MU. Pathology of the endometrium in women with chronic hepatitis C and HIV infection as a cause of unsuccessful in vitro fertilization attempts. Gynecological Endocrinology. 2015;31:1821.
  22. Hanafi N F, Abo Ali A.H, Abo el Kheir HF. ICSI outcome in women who have positive PCR result for hepatitis C virus. Human Reproduction. 2011;26(1):143-147.  https://doi.org/10.1093/humrep/deq317
  23. Englert Y, Moens E, Vannin AS, Liesnard C, Emiliani S, Delbaere A, Devreker F. Impaired ovarian stimulation during in vitro fertilization in women who are seropositive for hepatitis C virus and seronegative for human immunodeficiency virus. Fertility and Sterility. 2007;88(3):607-611.  https://doi.org/10.1016/j.fertnstert.2006.11.177
  24. Nie QH, Gao LH, Cheng YQ, Huang XF, Zhang YF, Luo XD, Wang JQ, Wang YY. Hepatitis C virus infection of human cytotrophoblasts cultured in vitro. Journal of Medical Virology. 2012;84(10):1586-1592. https://doi.org/10.1002/jmv.23380
  25. Giugliano S, Petroff MG, Warren BD, Jasti S, Linscheid C, Ward A, Kramer A, Dobrinskikh E, Sheiko MA, Gale M Jr, Golden-Mason L, Winn VD, Rosen HR. Hepatitis C virus sensing by human trophoblasts induces innate immune responses and recruitment of maternal NK cells: potential implications for limiting vertical transmission. The Journal of Immunology. 2015;195(8):3737-3747. https://doi.org/10.4049/jimmunol.1500409
  26. Quek JWE, Loo JH, Lim EQ, Chung AH, Othman ABB, Tan JJ, Barnett S, Nguyen MH, Wong YJ. Global epidemiology, natural history, maternal-to-child transmission, and treatment with DAA of pregnant women with HCV: a systematic review and meta-analysis. EClinicalMedicine. 2024;74:102727. https://doi.org/10.1016/j.eclinm.2024.102727
  27. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clinical Infectious Diseases. 2014;59(6):765-773.  https://doi.org/10.1093/cid/ciu447
  28. Curtis MR, Chappell C. Evidence for Implementation: HIV/HCV coinfection and pregnancy. Current HIV/AIDS Reports. 2023;20(1):1-8.  https://doi.org/10.1007/s11904-022-00643-9
  29. Ades AE, Gordon F, Scott K, Collins IJ, Thorne C, Pembrey L, Chappell E, Mariné-Barjoan E, Butler K, Indolfi G, Gibb DM, Judd A. Spontaneous clearance of vertically acquired hepatitis C infection: implications for testing and treatment. Clinical Infectious Diseases. 2023;76(5):913-991.  https://doi.org/10.1093/cid/ciac255
  30. Kushner T, Park C, Masand D, Rosenbluth E, Carroll C, Grace M, Rodriguez-Rivas C, De La Cruz H, Overbey J, Sperling R. Prevalence of elevated alanine aminotransferase (ALT) in pregnancy: A cross-sectional labor and delivery-based assessment. Medicine. 2022;101(40):e30408. https://doi.org/10.1097/MD.0000000000030408
  31. Dibba P, Cholankeril R, Li AA, Patel M, Fayek M, Dibble C, Okpara N, Hines A, Ahmed A. Hepatitis C in pregnancy. Diseases. 2018;6(2):31.  https://doi.org/10.3390/diseases6020031
  32. Money D, Boucoiran I, Wagner E, Dobson S, Kennedy A, Lohn Z, Krajden M, Yoshida EM. Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants. Journal of Obstetrics and Gynaecology Canada. 2014;36(9):785-794.  https://doi.org/10.1016/S1701-2163(15)30480-1
  33. Wijarnpreecha K, Thongprayoon C, Sanguankeo A, Upala S, Ungprasert P, Cheungpasitporn W. Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 2017; 41(1):39-45.  https://doi.org/10.1016/j.clinre.2016.07.004
  34. Piffer S, Mazza A, Dell’Anna L. Serological screening for hepatitis C during pregnancy: Seroprevalence and maternal and neonatal outcomes in 45,000 pregnant women. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2020;254:195-199.  https://doi.org/10.1016/j.ejogrb.2020.09.023
  35. Ragusa R, Corsaro LS, Frazzetto E, Bertino E, Bellia MA, Bertino G. Hepatitis C virus infection in children and pregnant women: an updated review of the literature on screening and treatments. American Journal of Perinatology Reports. 2020;10(1):e121-e127. https://doi.org/10.1055/s-0040-1709185
  36. Rezk M, Omar Z. Deleterious impact of maternal hepatitis-C viral infection on maternal and fetal outcome: a 5-year prospective study. Archives of Gynecology and Obstetrics. 2017;296(6):1097-1102. https://doi.org/10.1007/s00404-017-4550-2
  37. Huang QT, Huang Q, Zhong M, Wei SS, Luo W, Li F, Yu YH. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies. Journal of Viral Hepatitis. 2015;22(12):1033-42.  https://doi.org/10.1111/jvh.12430
  38. Adamyan LV, Sheshko EL, Dolgushina NV. Reproductive health and substance dependence: modern technology in diagnosis. Russian Journal of Human Reproduction. 2023;29(4):107-115. (In Russ.). https://doi.org/10.17116/repro202329041107
  39. Epstein RL, Espinosa C. Hepatitis C virus in neonates and infants. Clinics in Perinatology. 2021;48(2):343-357.  https://doi.org/10.1016/j.clp.2021.03.007
  40. Adamyan LV, Vechorko VI, Konysheva OV, Kharchenko EI, Doroshenko DA. Post-COVID-19 syndrome in obstetrics and reproductive medicine. Russian Journal of Human Reproduction. 2021;27(6): 30-40. (In Russ.). https://doi.org/10.17116/repro20212706130
  41. Adamyan LV, Vechorko VI, Konysheva OV, Kharchenko EI, Doroshenko DA, Fattakhova DN, Volkov SK. Post-COVID-19 consequences in obstetrics and reproductive medicine. Russian Journal of Human Reproduction. 2022;28(6):88-100. (In Russ.). https://doi.org/10.17116/repro20222806188
  42. Adamyan LV, Vechorko VI, Konysheva OV, Kharchenko EI, Doroshenko DA, Pivazyan LG. Post-COVID-19 and reproductive health (data from the survey and analysis of the results). Russian Journal of Human Reproduction. 2023;29(1):8693. (In Russ.). https://doi.org/10.17116/repro20232901186
  43. Adamyan L, Elagin V, Vechorko V, Stepanian A, Dashko A, Doroshenko D, Aznaurova Y, Sorokin M, Suntsova M, Drobyshev A, Garazha A, Buzdin A. COVID-19-associated inhibition of energy accumulation pathways in human semen samples. F&S Science. 2021;2(4):355-364.  https://doi.org/10.1016/j.xfss.2021.07.004
  44. Klinicheskie rekomendatsii. Normal’naya beremennost’. 2023. Odobreno Nauchno-prakticheskim Sovetom Ministerstva zdravookhraneniya Rossijskoj Federatsii. (In Russ.). Accessed December 18, 2024. https://slobodacrb.ru/images/stories/berem/1.pdf

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.